Endocrinol Metab.  2018 Mar;33(1):135-136. 10.3803/EnM.2018.33.1.135.

Active Surveillance of Papillary Thyroid Microcarcinoma: A Mini-Review from Korea (Endocrinol Metab 2017;32:399-406, Tae Yong Kim et al.)

Affiliations
  • 1Division of Thyroid Surgery, China-Japan Union Hospital of Jilin University, Changchun, China.
  • 2Jilin Provincial Key Laboratory of Surgical Translational Medicine, Changchun, China.
  • 3Division for Endocrine and Minimally Invasive Surgery, Department of Human Pathology in Adulthood and Childhood “G. Barresi”, University Hospital G. Martino, University of Messina, Messina, Italy. gdionigi@unime.it

Abstract

No abstract available.


MeSH Terms

Korea*
Thyroid Gland*

Reference

1. Kim TY, Shong YK. Active surveillance of papillary thyroid microcarcinoma: a mini-review from Korea. Endocrinol Metab (Seoul). 2017; 32:399–406.
Article
2. Kim HI, Jang HW, Ahn HS, Ahn S, Park SY, Oh YL, et al. High serum TSH level is associated with progression of papillary thyroid microcarcinoma during active surveillance. J Clin Endocrinol Metab. 2018; 103:446–451.
Article
3. Miyauchi A, Ito Y, Oda H. Insights into the management of papillary microcarcinoma of the thyroid. Thyroid. 2018; 28:23–31.
Article
4. Oda H, Miyauchi A, Ito Y, Yoshioka K, Nakayama A, Sasai H, et al. Incidences of unfavorable events in the management of low-risk papillary microcarcinoma of the thyroid by active surveillance versus immediate surgery. Thyroid. 2016; 26:150–155.
Article
5. An JH, Kim HY, Kim SG, Dralle H, Randolph GW, Piantanida E, et al. Endpoints for screening thyroid cancer in the Republic of Korea: thyroid specialists' perspectives. J Endocrinol Invest. 2017; 40:683–685.
Article
Full Text Links
  • ENM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr